CAIRO: Qatar researchers believe they have made a potential enormous breakthrough in how ovarian cancer can be treated. Researchers at Weill Cornell Medical College in Qatar (WCMC-Q) reported new techniques to tackle the disease. According to the researchers, the new approach studied smaller samples and revealed a deeper analysis of the genetic abnormalities in metastasized lesions and “found clear differences between the genetic expression of the primary ovarian cancer and the metastasized lesions.” This means that as doctors are treating ovarian cancer via traditional modern medication, the must also consider how lesions respond to those treatments and should be “tailoring the treatment based on combined biology of the primary ovarian cancer and metastatic lesions,” the college said. Jeremie Arash Rafii Tabrizi, Assistant Professor of Genetic Medicine in Obstetrics and Gynecology and Joel Malek, Director of the Genomics Laboratory and Instructor in Genetic Medicine, have been working closely with institutions in France, Singapore, Canada and the US to produce the report. The study has been published in PLoS ONE, the peer reviewed journal produced by the Public Library of Science. “Our findings are significant and important because most patients are diagnosed at the advanced stage of the disease,” Rafii said. “This means there are metastasized lesions present in the abdomen and by studying patients whose primary ovarian cancer is very similar, we have shown that the metastasized lesions, often the most dangerous part of the disease, are different. This means they may respond differently, possibly better, to a different cancer drug,” he said. BM ShortURL: http://goo.gl/6pWzP Tags: Ovarian Cancer, Treatment, Weill Cornell Medical College in Qatar Section: Health, Latest News, Qatar, Women
